Benznidazole Powder API Raw Materials

Product Name: Benznidazole Powder API Raw Materials

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Specification​: 99% min Benznidazole Powder

Test Method: HPLC

CAS: 22994-85-0

MF: C12H12N4O3

Sample: Benznidazole Powder

Keywords: Benznidazole Powder Supplier, Manufacturer, Benznidazole Powder Factory

A Brief introduction to Benznidazole:
Benznidazole Powder can be used as an intermediate in pharmaceutical synthesis. Benznidazole Anti-Inflammatory API Raw  Materials,Benznidazole Powder cas 22994-85-0 API Raw Materials,  ,Wholesale Benznidazole Powder from Manufacturer-Henrikang, Benznidazole Anti-Inflammatory API Raw Materials China Supplier | Manufacturer from Factory.
Benznidazole Powder can be used as an intermediate in pharmaceutical synthesis. If benzidine is inhaled, remove the patient to fresh air; In case of skin contact, remove contaminated clothing, wash skin thoroughly with soapy water and clean water, if discomfort, seek medical advice; In case of eye contact, separate eyelids, rinse with running water or normal saline, and seek medical attention immediately; If ingested, gargle immediately, do not induce vomiting, should seek medical attention immediately. Benznidazole (Radanil) is a nitroimidazole derivative, which can interfere with the biosynthesis of parasite proteins, affect the production of cytokines, and stimulate the phagocytosis of the host, and thus has antizoan activity.
Benznidazole is a yellowish crystalline powder, insoluble in water, slightly soluble in acetone and ethanol, has trypanosoma killing effect. It is mainly used for the treatment of American trypanosomiasis, and the cure rate of early trypanosomiasis can reach 80% ~ 90%. The U.S. Food and Drug Administration approved Benznidazole in 2017 for the treatment of children ages 2 to 12 with trypanosomiasis. FDA adopted accelerated approval when approving benznidazole for the treatment of Chagas disease, and granted it priority review designation. Previously, no drug had been approved by the FDA for the treatment of Chagas disease.